Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 comparison of LA-EP2006 versus Neulasta in breast cancer patients receiving TAC chemotherapy
2011-004532-58Phase 3Completed
- Sponsor
- Sandoz
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing LA-EP2006 with Neulasta (2 arms). Primary endpoint: Mean duration of Grade 4 neutropenia in Cycle 1. Started May 2012; status: completed.
02
Drugs
pegfilgrastim-bmezpegfilgrastim
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2011-004532-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004532-58.